166 related articles for article (PubMed ID: 35585092)
1. Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.
Salehi R; Abyar S; Ramazani F; Khandar AA; Hosseini-Yazdi SA; White JM; Edalati M; Kahroba H; Talebi M
Sci Rep; 2022 May; 12(1):8316. PubMed ID: 35585092
[TBL] [Abstract][Full Text] [Related]
2. In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes.
Abyar S; Khandar AA; Salehi R; Abolfazl Hosseini-Yazdi S; Alizadeh E; Mahkam M; Jamalpoor A; White JM; Shojaei M; Aizpurua-Olaizola O; Masereeuw R; Janssen MJ
Sci Rep; 2019 Oct; 9(1):14686. PubMed ID: 31604983
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
5. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a new platinum(II) complex: anticancer activity and nephrotoxicity in vitro.
Marzano C; Trevisan A; Giovagnini L; Fregona D
Toxicol In Vitro; 2002 Aug; 16(4):413-9. PubMed ID: 12110280
[TBL] [Abstract][Full Text] [Related]
7. Structure and biological properties of five Pt(II) complexes as potential anticancer agents.
Deng J; Wang J; Khan M; Yu P; Yang F; Liang H
J Inorg Biochem; 2018 Aug; 185():10-16. PubMed ID: 29730232
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural characterization, docking simulation and in vitro antiproliferative activity of the new gold(III) complex with 2-pyridineethanol.
Malik M; Bieńko DC; Komarnicka UK; Kyzioł A; Dryś M; Świtlicka A; Dyguda-Kazimierowicz E; Jedwabny W
J Inorg Biochem; 2021 Feb; 215():111311. PubMed ID: 33246642
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of thiosemicarbazone-functionalized organoruthenium (II)-arene complexes: Investigation of antitumor characteristics in colorectal cancer cell lines.
Subasi E; Atalay EB; Erdogan D; Sen B; Pakyapan B; Kayali HA
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110152. PubMed ID: 31753399
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities.
Qin QP; Wang SL; Tan MX; Liu YC; Meng T; Zou BQ; Liang H
Eur J Med Chem; 2019 Jan; 161():334-342. PubMed ID: 30384040
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Characterization of New Palladium(II) Thiosemicarbazone Complexes and Their Cytotoxic Activity against Various Human Tumor Cell Lines.
Hernández W; Paz J; Carrasco F; Vaisberg A; Spodine E; Manzur J; Hennig L; Sieler J; Blaurock S; Beyer L
Bioinorg Chem Appl; 2013; 2013():524701. PubMed ID: 24391528
[TBL] [Abstract][Full Text] [Related]
14. [Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.
Marković M; Knezević N; Momcilović M; Grgurić-Sipka S; Harhaji L; Trajković V; Mostarica Stojković M; Sabo T; Miljković D
Eur J Pharmacol; 2005 Jul; 517(1-2):28-34. PubMed ID: 15970285
[TBL] [Abstract][Full Text] [Related]
15. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro cytotoxicity of cis-[Pt(NH(3))(NH(2)OH)Cl(2)].
Ye QS; Liu WP; Chen XZ; Yu Y; Chang QW; Hou SQ
Arch Pharm Res; 2010 Jun; 33(6):807-11. PubMed ID: 20607484
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
18. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex.
Parsa FG; Feizi MAH; Safaralizadeh R; Hosseini-Yazdi SA; Mahdavi M
J Biol Inorg Chem; 2020 May; 25(3):383-394. PubMed ID: 32274578
[TBL] [Abstract][Full Text] [Related]
20. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
